Postpartum Contraception

Abstract

climates and interaction with other Federal programs, including Title X and 340B drug pricing program add complexity to states' ability to pay and deliver LARC to women. Specific policies such as the promotion of postpartum LARC insertion have been embraced by most states (8 of 9 sampled). Other policy innovations such as pharmacy stocking have been pursued less frequently (2 of 9 states).CONCLUSION: Current Medicaid LARC policies are heterogeneous and complex, which may hinder development of effective promotion and use of LARC as first line contraceptives for women who desire them. Policy makers should focus on eligibility, payment mechanisms and well-coordinated delivery systems to achieve optimal family planning care.